{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T09:30:18Z","timestamp":1783071018558,"version":"3.54.6"},"reference-count":37,"publisher":"American Chemical Society (ACS)","issue":"11","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR22123\/NNT\/28\/1120\/2016"],"award-info":[{"award-number":["BT\/PR22123\/NNT\/28\/1120\/2016"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["DST\/ INSPIRE Fellowship\/ 2018\/ IF180652"],"award-info":[{"award-number":["DST\/ INSPIRE Fellowship\/ 2018\/ IF180652"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol. Pharmaceutics"],"published-print":{"date-parts":[[2025,11,3]]},"DOI":"10.1021\/acs.molpharmaceut.5c00229","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:38:01Z","timestamp":1761219481000},"page":"6539-6551","source":"Crossref","is-referenced-by-count":3,"title":["cRGD-Functionalized Nanohybrid Conjugates Codelivering Temozolomide and Rapamycin for Treating Glioblastoma Multiforme:\n                    <i>In Vitro<\/i>\n                    and\n                    <i>In Vivo<\/i>\n                    Evaluation"],"prefix":"10.1021","volume":"22","author":[{"given":"Prabhjeet","family":"Singh","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Birla Institute of Technology and Science (BITS) Pilani, Pilani Campus, Vidya Vihar, Pilani 333 031, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3344-9579","authenticated-orcid":true,"given":"Anupama","family":"Mittal","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Birla Institute of Technology and Science (BITS) Pilani, Pilani Campus, Vidya Vihar, Pilani 333 031, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4174-7664","authenticated-orcid":true,"given":"Deepak","family":"Chitkara","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Birla Institute of Technology and Science (BITS) Pilani, Pilani Campus, Vidya Vihar, Pilani 333 031, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"ref1\/cit1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2022.08.024"},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.5603\/RPOR.a2022.0113"},{"key":"ref3\/cit3","unstructured":"K., Peters Avastin\/Temozolomide\/Irinotecan for Unresectable\/Multifocal Glioblastoma Multiforme. ClinicalTrials.gov identifier: NCT00979017. Updated March 19, 2014. (accessed Oct 01 2025)."},{"key":"ref4\/cit4","unstructured":"Duke University Bevacizumab in Combination With Metronomic Temozolomide\nfor Recurrent Malignant Glioma. ClinicalTrials.gov identifier:\nNCT00501891. Updated May 27, 2013. (accessed Oct 01 2025)."},{"key":"ref5\/cit5","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26381"},{"key":"ref6\/cit6","unstructured":"Sidney Kimmel Comprehensive\nCancer Center at Johns Hopkins. Hydroxychloroquine, Radiation, and Temozolomide Treating Patients\nWith Newly Diagnosed Glioblastoma Multiforme. ClinicalTrials.gov identifier:\nNCT00486603.Updated July 10, 2019. (accessed Oct 01 2025)."},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5405"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-3389"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050008"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2012.11.044"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23855"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noq193"},{"key":"ref13\/cit13","doi-asserted-by":"publisher","DOI":"10.1016\/j.trre.2005.01.001"},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2.11.1903"},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7896"},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2020.1785049"},{"key":"ref17\/cit17","doi-asserted-by":"publisher","DOI":"10.2217\/nnm-2017-0011"},{"key":"ref18\/cit18","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.s247893"},{"key":"ref19\/cit19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajps.2025.101022"},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.8b00228"},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2021.112305"},{"issue":"1","key":"ref22\/cit22","first-page":"97","volume":"6","author":"Zhang N.","year":"2016","journal-title":"Am. J. Cancer Res."},{"key":"ref23\/cit23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2023.05.012"},{"key":"ref24\/cit24","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2012.01.005"},{"key":"ref25\/cit25","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.7537"},{"key":"ref26\/cit26","unstructured":"Aadi Bioscience, Inc. Nab-sirolimus in Recurrent High Grade\nGlioma and Newly Diagnosed Glioblastoma. ClinicalTrials.gov identifier:\nNCT03463265. Updated November 07, 2023. (accessed Oct 01 2025)."},{"key":"ref27\/cit27","unstructured":"DrugBank. Sirolimus. https:\/\/go.drugbank.com\/drugs\/DB00877 (accessed Jun 09 2025)."},{"key":"ref28\/cit28","doi-asserted-by":"publisher","DOI":"10.1007\/s12247-019-09406-3"},{"key":"ref29\/cit29","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2012.07.046"},{"key":"ref30\/cit30","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.6b15831"},{"key":"ref31\/cit31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.105173"},{"key":"ref32\/cit32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2007.01.016"},{"key":"ref33\/cit33","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2012.06.026"},{"key":"ref34\/cit34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2017.04.033"},{"key":"ref35\/cit35","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S70919"},{"key":"ref36\/cit36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2019.101423"},{"key":"ref37\/cit37","doi-asserted-by":"publisher","DOI":"10.1038\/srep31539"}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.5c00229","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.5c00229","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:11:43Z","timestamp":1762161103000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.molpharmaceut.5c00229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11,3]]}},"alternative-id":["10.1021\/acs.molpharmaceut.5c00229"],"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5c00229","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]}}}